Published

Trial of Psilocybin versus Escitalopram for Depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The New England journal of medicine
Date: 2021-04-15
Source: PubMed
DOI: 10.1056/nejmoa2032994
PubMed: 33852780

Authors

Carhart-Harris R Giribaldi B Watts R Baker-Jones M Murphy-Beiner A Murphy R Martell J Blemings A Erritzoe D Nutt DJ

Watch author

Derived topics and classifications

psilocybin Depression Receptor Pharmacology Clinical Trial Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases2026-09-01 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis2026-08-01 Longitudinal neural and psychological changes following psilocybin under compassion imagery priming2026-07-22 Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder2026-07-16 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13 CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder2026-07-07 Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits2026-07-01 Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence2026-07-01 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats2026-07-01 Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01 Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats2026-06-01 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27 Human brain changes after first psilocybin use2026-05-05 Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms2026-05-01

Related papers

Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.American journal of therapeutics · 2024-01-01 Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsClinicalTrials.gov · 2024-10-24 Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2020-12-01